PATIENT EXPERIENCES WITH THREE-MONTHLY PALIPERIDONE PALMITATE FOR THE MANAGEMENT OF SCHIZOPHRENIA

被引：0
|
作者：
Brahmbhatt, P. [1 ]
机构：
[1] Lower North Shore Mental Hlth, Sydney, NSW, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2017年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [1] Paliperidone palmitate three-monthly formulation for the management of schizophrenia
    Wilkinson, Loren
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2017, 26 : 43 - 43
  • [2] PALIPERIDONE PALMITATE THREE-MONTHLY FORMULATION FOR THE MANAGEMENT OF SCHIZOPHRENIA
    Gopal, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 103 - 104
  • [3] SCHIZOPHRENIA MANAGEMENT: REAL-WORLD EXPERIENCE FROM NEW ZEALAND USING THREE-MONTHLY PALIPERIDONE PALMITATE
    Cassidy, C.
    Miles, W.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 84 - 84
  • [4] ASSESSING THE COST-EFFECTIVENESS OF THREE-MONTHLY PALIPERIDONE PALMITATE VERSUS ITS PRIOR MONTHLY FORMULATION FOR THE MANAGEMENT OF SCHIZOPHRENIA IN THE UK SETTING
    Arteaga, C.
    Nilforooshan, R.
    Lee, J.
    Ming, T.
    Bird, A.
    van Gils, C. W.
    VALUE IN HEALTH, 2018, 21 : S185 - S185
  • [5] Patients' perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate - a qualitative interview study
    Rise, Marit B.
    Stolan, Liv Os
    Erdner, Anette
    Hedberg, Berith
    Stahl, Katja
    Riise, Jesper
    Jedenius, Erik
    Mollerhoj, Jette
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (04) : 257 - 265
  • [6] Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
    Wallman, Phoebe
    Clark, Ivana
    Taylor, David
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (09) : 1091 - 1098
  • [7] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Xin Li
    Chong Ye
    Wanyi Zhang
    Miaomiao Jia
    Gang Wang
    CNS Drugs, 2024, 38 : 55 - 65
  • [8] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Li, Xin
    Ye, Chong
    Zhang, Wanyi
    Jia, Miaomiao
    Wang, Gang
    CNS DRUGS, 2024, 38 (01) : 55 - 65
  • [9] Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
    Li, Gang
    Keenan, Alexander
    Daskiran, Mehmet
    Mathews, Maju
    Nuamah, Isaac
    Orman, Camille
    Joshi, Kruti
    Singh, Arun
    Godet, Annabelle
    Pungor, Katalin
    Gopal, Srihari
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 2239 - 2248
  • [10] Clinical management of medication overdose: Three-monthly paliperidone palimitate injectable medication
    Parker, Robert
    Vellar, Kane
    Khalid, Usman
    Wood, Daniel
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (04): : 413 - 413
12345